Cargando…

Health technology assessment: oncology drugs with orphan designation as an example

Detalles Bibliográficos
Autor principal: Wild, Claudia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958374/
http://dx.doi.org/10.1186/1750-1172-5-S1-O17
_version_ 1782188329313239040
author Wild, Claudia
author_facet Wild, Claudia
author_sort Wild, Claudia
collection PubMed
description
format Text
id pubmed-2958374
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29583742010-10-22 Health technology assessment: oncology drugs with orphan designation as an example Wild, Claudia Orphanet J Rare Dis Oral Presentation BioMed Central 2010-10-19 /pmc/articles/PMC2958374/ http://dx.doi.org/10.1186/1750-1172-5-S1-O17 Text en Copyright ©2010 Wild; licensee BioMed Central Ltd.
spellingShingle Oral Presentation
Wild, Claudia
Health technology assessment: oncology drugs with orphan designation as an example
title Health technology assessment: oncology drugs with orphan designation as an example
title_full Health technology assessment: oncology drugs with orphan designation as an example
title_fullStr Health technology assessment: oncology drugs with orphan designation as an example
title_full_unstemmed Health technology assessment: oncology drugs with orphan designation as an example
title_short Health technology assessment: oncology drugs with orphan designation as an example
title_sort health technology assessment: oncology drugs with orphan designation as an example
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958374/
http://dx.doi.org/10.1186/1750-1172-5-S1-O17
work_keys_str_mv AT wildclaudia healthtechnologyassessmentoncologydrugswithorphandesignationasanexample